BioPharma Resources

Drug Trial Radar · NCT07538583

Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome

A Multicenter, Open-label Study of QRX003 Lotion in Participants With Netherton Syndrome

Last checked: Nov 19, 2026Latest source record: Sep 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

16

Planned (sponsor's estimate)

Start

Mar 19, 2026

Primary completion

Jan 31, 2027

Study completion Mar 31, 2027

Sponsor

Lead sponsor
Quoin PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Apr 20, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 4 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter, open-label study to evaluate the safety, tolerability, and efficacy of 4% QRX003 lotion applied twice daily (BID) for 12 weeks to Netherton syndrome (NS) diseased skin in all affected areas of the body excluding the scalp (the Treatment Area), totaling approximately 50% Body Surface Area (BSA) or more.

Conditions

  • Netherton Syndrome

Interventions

  • QRX003Drug

    Serine Protease Inhibitor

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of subjects with 1-point reduction on IGATime frame: Week 12

Locations

8 sites in 2 countries. Site status is shown where the registry gives one.

  • Center for Dermatology Clinical Research

    Fremont, California · Recruiting

  • Yale University School of Medicine

    New Haven, Connecticut · Not yet recruiting

  • Dawes Fretzin Clinical Reseacrh Group

    Indianapolis, Indiana · Recruiting

  • Beacon Clinical Research

    Quincy, Massachusetts · Recruiting

  • Texas Dermatology and Laser Specialists

    San Antonio, Texas · Recruiting

  • Guy's Hospital, Skin Therapy Research Unit

    London, United Kingdom · Recruiting

  • Great Ormond Street Hospital, NIHR - Clinical Research

    London, England, United Kingdom · Recruiting

  • Walsall Manor Hospital, Research & Development

    Walsall, West Midlands, United Kingdom · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.